Original Research
Published on 19 May 2022
Low Dose Interleukin-2 Ameliorates Sjögren’s Syndrome in a Murine Model
in Rheumatology
Frontiers in Medicine
doi 10.3389/fmed.2022.887354
- 5,669 views
- 9 citations
Original Research
Published on 19 May 2022
in Rheumatology
Original Research
Published on 02 Nov 2015
in NK and Innate Lymphoid Cell Biology